Cargando…
PROTAC induced-BET protein degradation exhibits potent anti-osteosarcoma activity by triggering apoptosis
Targeting oncogenic proteins for degradation using proteolysis-targeting chimera (PROTAC) recently has drawn increasing attention in the field of cancer research. Bromodomain and extra-terminal (BET) family proteins are newly identified cancer-related epigenetic regulators, which have a role in the...
Autores principales: | Shi, Chengcheng, Zhang, Huapeng, Wang, Penglei, Wang, Kai, Xu, Denghui, Wang, Haitao, Yin, Li, Zhang, Shuijun, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814818/ https://www.ncbi.nlm.nih.gov/pubmed/31653826 http://dx.doi.org/10.1038/s41419-019-2022-2 |
Ejemplares similares
-
Targeting BET Proteins With a PROTAC Molecule Elicits Potent Anticancer Activity in HCC Cells
por: Zhang, Huapeng, et al.
Publicado: (2020) -
Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs
por: Qin, Qiaohua, et al.
Publicado: (2022) -
Developing potent PROTACs tools for selective degradation of HDAC6 protein
por: An, Zixuan, et al.
Publicado: (2019) -
Discovery of
a Highly Potent and Selective Dual PROTAC
Degrader of CDK12 and CDK13
por: Yang, Jianzhang, et al.
Publicado: (2022) -
Bromodomain and BET family proteins as epigenetic targets in cancer therapy: their degradation, present drugs, and possible PROTACs
por: Muddassir, Mohd., et al.
Publicado: (2020)